AUG 13, 2026 · PHASE 2 TRIAL
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov
This is a Phase 2 trial registration with no results reported; it describes a planned study of experimental agents in advanced NSCLC with surrogate endpoints (objective response by RECIST), requiring completion and results publication before evidence strength can be assessed.
Reported
Planned enrollment300
PhasePhase 2
Primary outcome measureObjective response as assessed by investiga…